Free Trial

Envista (NYSE:NVST) Rating Lowered to "Hold" at Robert W. Baird

Envista logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Robert W. Baird downgraded Envista from “strong buy” to “hold,” contributing to an overall analyst consensus rating of “Hold.” The consensus price target is $28.86, with six analysts rating the stock a Buy and eleven assigning a Hold.
  • Envista reported quarterly EPS of $0.41, beating estimates of $0.34, while revenue rose 7.1% year over year to $730.5 million. The company maintained fiscal 2026 EPS guidance of $1.50–$1.55.
  • Shares opened at $23.49, below the 50-day and 200-day moving averages of approximately $25.56 and $25.65, respectively. An Envista senior vice president also sold 8,000 shares worth $220,000 under a pre-arranged trading plan.
  • Five stocks to consider instead of Envista.

Envista (NYSE:NVST - Get Free Report) was downgraded by Robert W. Baird from a "strong-buy" rating to a "hold" rating in a research report issued to clients and investors on Thursday, Zacks reports.

Several other research analysts have also recently commented on the stock. Morgan Stanley set a $23.00 target price on shares of Envista in a research report on Thursday, August 6th. Wall Street Zen cut Envista from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 5th. Needham & Company LLC reiterated a "hold" rating on shares of Envista in a research report on Friday, September 18th. Deutsche Bank Aktiengesellschaft set a $32.00 price objective on Envista in a report on Thursday, September 3rd. Finally, Leerink Partners decreased their price objective on Envista from $35.00 to $32.00 and set an "outperform" rating for the company in a report on Wednesday. Six research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $28.86.

View Our Latest Research Report on NVST

Envista Price Performance

Shares of NYSE NVST opened at $23.49 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The firm has a market capitalization of $3.77 billion, a PE ratio of 40.50, a P/E/G ratio of 1.16 and a beta of 0.89. Envista has a 1-year low of $18.77 and a 1-year high of $30.42. The business's fifty day moving average price is $25.56 and its two-hundred day moving average price is $25.65.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. During the same quarter in the previous year, the company posted $0.26 earnings per share. The company's revenue for the quarter was up 7.1% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, research analysts expect that Envista will post 1.53 EPS for the current year.

Insiders Place Their Bets

In related news, SVP Mischa Reis sold 8,000 shares of the company's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the completion of the sale, the senior vice president owned 27,321 shares of the company's stock, valued at $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is owned by insiders.

Hedge Funds Weigh In On Envista

Several large investors have recently bought and sold shares of NVST. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Envista in the second quarter valued at approximately $25,000. Nykredit A S bought a new stake in Envista during the second quarter worth approximately $52,000. C M Bidwell & Associates Ltd. bought a new stake in Envista during the second quarter worth approximately $63,000. Elevation Wealth Partners LLC lifted its position in Envista by 262.9% in the third quarter. Elevation Wealth Partners LLC now owns 2,406 shares of the company's stock worth $56,000 after purchasing an additional 1,743 shares during the period. Finally, Parkside Financial Bank & Trust lifted its position in Envista by 246.2% in the second quarter. Parkside Financial Bank & Trust now owns 3,071 shares of the company's stock worth $81,000 after purchasing an additional 2,184 shares during the period.

Envista Company Profile

(Get Free Report)

Envista Holdings Corporation NYSE: NVST is a global dental-products and technologies company that develops, manufactures and markets equipment, consumables and digital solutions for dental professionals, laboratories and specialists. Its offerings support diagnosis, treatment planning, restorative dentistry, orthodontics, implant dentistry and related clinical procedures.

The company's portfolio includes dental imaging systems and software, treatment units, handpieces, infection-control products, restorative materials, endodontic products, orthodontic brackets and aligners, dental implants, prosthetic components and laboratory solutions.

See Also

Analyst Recommendations for Envista (NYSE:NVST)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines